Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lantheus Germany Gmbh

Clinical trials sponsored by Lantheus Germany Gmbh, explained in plain language.

Now part of Lantheus Holdings, Inc. LNTH NASDAQ

German subsidiary of Lantheus, a company specializing in diagnostic imaging agents.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Completed 1

New imaging agent could spot hidden heart disease

Diagnosis Recruiting now

This study tests whether a radioactive tracer called Florbetaben F18 can reliably detect amyloid deposits in the heart using PET scans. Researchers will scan 15 people with and without cardiac amyloidosis twice to see if the results are consistent. The goal is to improve diagnosi…

Phase: PHASE1 • Sponsor: Lantheus Germany GmbH • Aim: Diagnosis

Last updated Aug 05, 2026 00:00 UTC